Statin use not linked to COVID-19 mortality in hospitalized patients
Nov 09, 2021
Statin use was associated with an increased relative risk for severe disease among hospitalized patients with COVID-19.
COVID-19 vaccine primary series coverage 76 percent in adults 60 years and older
Feb 06, 2023
Primary series coverage by the end of 2022 was below the 100% target set for at-risk populations.
Adverse effects generally mild after BNT162b2 mRNA booster in over 60s
Apr 18, 2022
Thirty percent of those aged 60 years or older receiving a booster reported at least one adverse event; few sought medical attention.
Disparities in COVID-19 vaccination identified among healthcare employees
Jun 16, 2021
Vaccination was least likely among clinical nurses, support staff and workers at skilled nursing and rehabilitation facilities.
Pfizer-BioNTech COVID-19 vaccine receives full FDA approval
Aug 23, 2021
The vaccine will now be marketed as Comirnaty and is fully approved for the prevention of COVID-19 in individuals 16 years and older.
Thrombosis, thrombocytopenia syndrome up after Ad26.COV2.S
Jan 28, 2022
Rates of 3.83 per million vaccine doses for Ad26.COV2.S (Johnson & Johnson) have been reported, versus 0.00855 per million for mRNA-based vaccines such as Pfizer-BioNTech and Moderna.
Myocarditis, myopericarditis risk up after SARS-CoV-2 vaccination
Dec 17, 2021
SARS-CoV-2 mRNA vaccination is associated with a significantly increased risk for myocarditis or myopericarditis for those receiving the mRNA-1273 (Moderna) vaccine and among females receiving the BNT162b2...
CDC advises updated COVID vaccine for everyone over 6 months of age
Jun 28, 2024
Americans 65 and older account for two-thirds of COVID hospitalizations and 82% of in-hospital deaths, yet only about 40% of Americans in that age group were immunized with the COVID vaccines that were...